These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of patients with destructive pulmonary tuberculosis and nonspecific purulent endobronchitis].
    Author: Pletnev GV, Krasnov VA, Potashova VA.
    Journal: Probl Tuberk; 2003; (2):33-5. PubMed ID: 12790031.
    Abstract:
    Imozymase treatment should be started from the first hospital days in patients with destructive pulmonary tuberculosis concurrent with nonspecific purulent endobronchitis. Two-week ultrasound inhalations with imozymase in a dose of 1 ml (60 PU) may rapidly abolish not only the nonspecific inflammatory bronchial process, but also accelerate the attenuation of symptoms of intoxication, the time of abacillation, cavernous closure, and preparation for surgical interventions.
    [Abstract] [Full Text] [Related] [New Search]